Structure Therapeutics is trading at $48.00 (4.3%) up in after-hours trading as investors reassess recent volatility tied to insider selling and profit-taking.
- The stock fell sharply earlier on July 16, 2026, following news of share sales by the Chief Scientific Officer.
- The insider selling occurred after a major rally driven by positive updates regarding the company's obesity-drug pipeline.
- The after-hours bounce suggests bargain-hunting and stabilization as the market absorbs the impact of the recent pullback.